Healthcommunities.com

Home Health Topics Health Reports Learning Centers Find a Dermatologist Medical Website Design
|
|

Port-wine Stain Diagnosis, Treatment

Port-wine Stain Diagnosis

Port-wine stains are diagnosed mainly by their appearance.

Infants with a port-wine stain that involves the upper and lower eyelids usually undergo a magnetic resonance imaging (MRI) scan or other type of brain scan. This can help the physician diagnose or exclude Sturge-Weber syndrome.

Approximately 5% of infants with a port-wine stain on the eyelids are at risk for this condition, in which the lesion involves the trigeminal nerve, the eye, the meninges (thin membrances surrounding the brain), and the brain. Seizures occur in about 80% of patients afflicted. Glaucoma, developmental delays, and partial paralysis are other aspects of Sturge-Weber syndrome.

An extensive port-wine stain on a limb can result in varicose veins and locally enlarged skin, tissues, and bones. This is a very rare condition called Klippel-Trenaunay syndrome.

Article Continues Below



Treatment for Port-wine Stains

Pulsed-dye laser offers safe and effective treatment for port-wine stains. Treatment success depends on the age at which it is begun and the location of the lesion. With multiple treatments, most port-wine stains can be significantly lightened. Topical, local, or general anesthesia can be administered before the procedure to minimize discomfort.

Port-wine Stain Prevention

Port-wine stains cannot be prevented. If the child has Sturge-Weber syndrome, an ophthalmologist and neurologist should be consulted soon after the diagnosis to reduce the risk for glaucoma and seizures. For more information, contact the
Sturge-Weber Foundation
P.O. Box 418
Mount Freedom, New Jersey

phone:
www.sturge-weber.com.


  • « Port-wine Stain Overview, Cause, Symptoms

Physician-developed and -monitored.
Original Date of Publication: 01 Sep 2000
Reviewed by: Stanley J. Swierzewski, III, M.D.
Last Reviewed: 04 Dec 2007
Last Modified:16 Feb 2011

© Healthcommunities.com, Inc. All Rights Reserved.

More on Blood Vessel Disorders (11 of 12 articles)

Pyogenic Granuloma

Read More »


  • Turn Down the Thermostat to Burn Fat?
  • Sleep-Deprived Kids May Be at Risk for Childhood Obesity
  • Allegra Approved for Over-the-Counter Sales
  • Cognitive Behavioral Therapy Helps Prevent a Second Heart Attack
  • FDA Approves Vilazodone for Major Depression
  • Behavioral Therapy Effective Insomnia Treatment for Older People
  • Health Tips from TV's The Doctors
  • Can the Drug TXA Save Lives?
  • Statin Use for Prevention of Heart Disease Questioned
  • Study Identifies Avoidable Breast Cancer Risk Factors
  • Zolpidem Side Effects Include Imbalance, Cognitive Impairment
  • Finding the Right Breast Cancer Doctor Affects Treatment Outcomes
  • When Is it OK to Stop Breastfeeding Exclusively?
  • Barriers to Skin Cancer Screening Revealed
  • Therapy Helps with Incontinence after Prostatectomy, Study Finds
  • AHA Issues Call for Reduced Sodium in Diets
  • Study Finds NSAID Side Effects Troubling
  • Sedentary Lifestyle & Heart Disease Risk
  • Study about Truvada® for HIV/AIDS Prevention
  • FDA Limits Prescription Acetaminophen Dosage, Requires "Black Box" Warning


Specialties

Allergy

Alternative Medicine

Animal Health

Avian Flu

BPH

Cardiology

Diabetes

Dermatology

Flu

GI

General Health

HIV

LGBT Health

Male Health

Mental Health

Nephrology

Neurology

Oncology

Pain

Pediatric Health

Podiatry

Pulmonology

Radiology

Rheumatology

Senior Health

Sexual Health

Sleep Disorder

Surgery

Urology

Vision

Women's Health


Remedy Health Media logo
Healthcommunities.com® | Intelecare® | RemedyLife™ | JohnsHopkinsHealthAlerts.com | BerkeleyWellnessAlerts.com | WellnessLetter.com
Diabetes Focus® | Remedy's Healthy Living™ | Remedy® | RemedyKids™ | RemedyMD™
© 2011 Remedy Health Media, LLC. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information:
verify here.